A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Insulet Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 100,100 shares of PODD stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,100
Previous 149,700 33.13%
Holding current value
$19.9 Million
Previous $32.5 Million 47.18%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$163.6 - $209.11 $55.1 Million - $70.5 Million
337,098 Added 25.32%
1,668,492 $286 Million
Q4 2023

Feb 14, 2024

SELL
$127.77 - $221.42 $8.74 Million - $15.2 Million
-68,437 Reduced 4.89%
1,331,394 $289 Million
Q3 2023

Nov 14, 2023

BUY
$154.67 - $290.89 $169 Million - $318 Million
1,094,792 Added 358.9%
1,399,831 $223 Million
Q2 2023

Aug 14, 2023

BUY
$272.48 - $330.23 $69 Million - $83.6 Million
253,091 Added 487.2%
305,039 $88 Million
Q1 2023

May 15, 2023

SELL
$276.36 - $326.03 $1.19 Million - $1.4 Million
-4,307 Reduced 7.66%
51,948 $16.6 Million
Q4 2022

Feb 14, 2023

BUY
$212.22 - $313.46 $7.89 Million - $11.7 Million
37,177 Added 194.87%
56,255 $16.6 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $4.05 Million - $5.08 Million
18,037 Added 1732.66%
19,078 $4.38 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $14.6 Million - $21.9 Million
-78,312 Reduced 98.69%
1,041 $227,000
Q1 2022

May 16, 2022

BUY
$194.8 - $275.7 $3.86 Million - $5.46 Million
19,805 Added 33.26%
79,353 $21.1 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $11.7 Million - $14.6 Million
45,830 Added 334.09%
59,548 $15.8 Million
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $76.1 Million - $89.8 Million
-292,116 Reduced 95.51%
13,718 $3.9 Million
Q2 2021

Aug 16, 2021

SELL
$225.52 - $304.06 $77.1 Million - $104 Million
-341,960 Reduced 52.79%
305,834 $84 Million
Q1 2021

May 17, 2021

BUY
$235.95 - $293.05 $52.6 Million - $65.3 Million
222,826 Added 52.43%
647,794 $169 Million
Q4 2020

Feb 16, 2021

BUY
$215.97 - $265.89 $39.5 Million - $48.6 Million
182,942 Added 75.59%
424,968 $109 Million
Q3 2020

Nov 16, 2020

SELL
$192.55 - $236.59 $40.4 Million - $49.7 Million
-209,982 Reduced 46.46%
242,026 $57.3 Million
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $2.52 Million - $3.56 Million
15,851 Added 3.63%
452,008 $87.8 Million
Q1 2020

May 15, 2020

BUY
$130.01 - $216.44 $25.8 Million - $42.9 Million
198,335 Added 83.4%
436,157 $72.3 Million
Q4 2019

Feb 14, 2020

BUY
$144.81 - $186.0 $20 Million - $25.7 Million
137,924 Added 138.06%
237,822 $40.7 Million
Q3 2019

Nov 14, 2019

SELL
$117.35 - $167.95 $60 Million - $85.9 Million
-511,202 Reduced 83.65%
99,898 $16.5 Million
Q2 2019

Aug 14, 2019

BUY
$82.13 - $120.73 $3.39 Million - $4.98 Million
41,246 Added 7.24%
611,100 $73 Million
Q1 2019

May 15, 2019

BUY
$72.44 - $101.87 $27.5 Million - $38.6 Million
379,295 Added 199.04%
569,854 $0
Q4 2018

Feb 14, 2019

SELL
$73.27 - $105.19 $15 Million - $21.5 Million
-204,203 Reduced 51.73%
190,559 $15.1 Million
Q3 2018

Nov 13, 2018

SELL
$81.43 - $108.13 $4.23 Million - $5.62 Million
-51,960 Reduced 11.63%
394,762 $0
Q2 2018

Aug 10, 2018

BUY
$83.27 - $101.93 $35.3 Million - $43.2 Million
423,470 Added 1821.22%
446,722 $0
Q1 2018

May 11, 2018

SELL
$68.49 - $87.2 $606,204 - $771,807
-8,851 Reduced 27.57%
23,252 $2.02 Million
Q4 2017

Feb 09, 2018

BUY
$55.67 - $71.8 $1.21 Million - $1.56 Million
21,720 Added 209.19%
32,103 $2.21 Million
Q3 2017

Nov 09, 2017

BUY
$49.68 - $59.46 $515,827 - $617,373
10,383
10,383 $572,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $13.8B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.